ACDE Webinar | Antiresorptive Medications and MRONJ

You'll receive an overview of Osteonecrosis of the Jaw (ONJ) and Medication-Related Osteonecrosis of the Jaw (MRONJ), focusing on understanding its types, definitions, causes, and management strategies. Learn to identify and describe the three primary types of ONJ and the core elements that define MRONJ. The indications for antiresorptive medications, exploring the mechanisms of action for drugs like Denosumab and Bisphosphonates, detailing both anabolic and anti-catabolic medication categories, will be discussed. You will learn about the pathophysiology, stages, and predisposing factors of MRONJ, gaining a solid foundation for understanding its progression and impact, treatment goals, the American Association of Oral and Maxillofacial Surgeons (AAOMS) guidelines, and local wound care practices that promote healing. You will examine the "4 Ds" of antiresorptive therapy, the delayed dosing protocol, and specialized decision-making tools, such as the extraction and MRONJ decision trees for Complex Dental Management and Assessment (CDMA) cases. Through these elements, you will leave this course equipped with practical strategies and evidence-based approaches for managing MRONJ in clinical settings.